LA JOLLA, Calif.--(BUSINESS WIRE)--May 16, 2006--Stratagene Corporation (Nasdaq:STGN - News), a developer, manufacturer and marketer of specialized life science research and diagnostic products, has recently settled litigation and significantly strengthened its patent portfolio pertaining to proprietary enzyme blends.
